Becton Dickinson/CareFusion Deal Not a Threat to Omnicell (OMCL) - Analyst
Tweet Send to a Friend
FBR Capital analyst Steven Halper reiterated an Outperform rating and $31 price target on Omnicell (NASDAQ: OMCL) Monday, saying Becton ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
